- EMB-FUBINACA
- FUB-AEB
- Ethyl N-{1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}-L-valinate
- Ethyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate
Liu, C; Jia, W; Hua, Z; Qian, Z. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F–NPB-22-7N, 5F–AKB-48-7N, 5F–EDMB-PINACA, EMB-FUBINACA, and EG-018 Drug Test. Anal., 1 Aug 2017, 9 (8), 1251–1261. 1.8 MB. https://doi.org/10.1002/dta.2160 #5 LC,MS,NMR
Doi, T; Tagami, T; Takeda, A; Asada, A; Sawabe, Y. Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers Forensic Toxicol., 1 Jan 2018, 36 (1), 51-60. 698 kB. https://doi.org/10.1007/s11419-017-0378-5 #14 NMR
EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #51
Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report) Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #8. EMB-FUBINACA